Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Arrhythmias

Free Subscription 22.04.2024 1 Am Heart J 1 Am J Cardiol 1 Am J Emerg Med 1 Ann Thorac Surg 3 BMJ 1 Cardiovasc Res 9 Circ Arrhythm Electrophysiol 2 Circ Genom Precis Med 1 Circ Res 2 Circulation 1 Clin Cardiol 2 Eur Heart J 1 Heart 1 J Am Coll Cardiol 1 J Cardiol 2 J Cardiovasc Electrophysiol 12 J Interv Card Electrophysiol 3 J Thromb Thrombolysis 3 N Engl J Med 1 Pacing Clin Electrophysiol 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. KEEPANASSERIL A, Pande SN, Suriya Y, Baghel J, et al
   "Comparing the Outcomes of Rheumatic Heart Disease in Pregnancy Complicated with and without Atrial Fibrillation: A Propensity Score Matched Analysis".
   Am Heart J. 2024 Apr 11:S0002-8703(24)00089-9. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. ALMANI MU, Talha KM, Khan LA, Hameed I, et al
   Prevalence and Predictors of Readmissions Among Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter.
   Am J Cardiol. 2024 Apr 16:S0002-9149(24)00269.
   PubMed         Abstract available
   
   

   
   Am J Emerg Med

3. PASLI S, Topcuoglu H, Yilmaz M, Yadigaroglu M, et al
   Diagnostic accuracy of apple watch ECG outputs in identifying dysrhythmias: A comparison with 12-Lead ECG in emergency department.
   Am J Emerg Med. 2024;79:25-32.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

4. TAM DY, Kiankhooy A
   An essential update but are the 2023 Surgical Treatment of Atrial Fibrillation Guidelines enough?
   Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00283.
   PubMed        
   
   

   
   BMJ

5. WU J, Nadarajah R
   The growing burden of atrial fibrillation and its consequences.
   BMJ. 2024;385:q826.
   PubMed        
   
   
6. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
   Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
   BMJ. 2024;385:e077209.
   PubMed         Abstract available
   
   
7. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
   Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
   BMJ. 2024;385:e076268.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

8. FABRITZ L, Chua W, Cardoso VR, Al-Taie C, et al
   Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study.
   Cardiovasc Res. 2024 Apr 13:cvae067. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Arrhythm Electrophysiol

9. BUNCH TJ, Poole JE, Silverstein AP, Lee KL, et al
   Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA Trial.
   Circ Arrhythm Electrophysiol. 2024 Apr 17:e012697.
   PubMed         Abstract available
   
   
10. TREJO-PAREDES C, Lampert R
    The Science Behind the Standardization of Chest Protectors: Is Marketing Alone Enough to Sell Chest Protectors?... Not Anymore!
    Circ Arrhythm Electrophysiol. 2024;17:e012844.
    PubMed        
    
    
11. PANNONE L, Bisignani A, Osei R, Gauthey A, et al
    Genetic Testing in Brugada Syndrome: A 30-Year Experience.
    Circ Arrhythm Electrophysiol. 2024;17:e012374.
    PubMed         Abstract available
    
    
12. RODRIGUEZ NA, Patel N, Dariolli R, Ng S, et al
    HRAS-Mutant Cardiomyocyte Model of Multifocal Atrial Tachycardia.
    Circ Arrhythm Electrophysiol. 2024;17:e012022.
    PubMed         Abstract available
    
    
13. KAWAGUCHI N, Tanaka Y, Okubo K, Tachibana S, et al
    Differential Pacing Maneuver From the Vein of Marshall.
    Circ Arrhythm Electrophysiol. 2024;17:e012420.
    PubMed         Abstract available
    
    
14. FARIDI KF, Ong EL, Zimmerman S, Varosy PD, et al
    Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion.
    Circ Arrhythm Electrophysiol. 2024 Feb 23:e012424.
    PubMed         Abstract available
    
    
15. DAU N, Bir C, McCalley E, Halstead D, et al
    Development of the NOCSAE Standard to Reduce the Risk of Commotio Cordis.
    Circ Arrhythm Electrophysiol. 2024;17:e011966.
    PubMed         Abstract available
    
    
16. YAMADA T, Kay GN
    Trends Favoring an Anatomical Approach to Radiofrequency Catheter Ablation of Idiopathic Ventricular Arrhythmias Originating From the Left Ventricular Summit.
    Circ Arrhythm Electrophysiol. 2024 Apr 17:e012548.
    PubMed         Abstract available
    
    
17. SCHILL MR, Vijayakumar R, Yates TA, McGilvray MMO, et al
    Sinus Rhythm Atrial Electrocardiographic Imaging in Patients With Mitral Regurgitation: Clues to the Substrate for Atrial Fibrillation.
    Circ Arrhythm Electrophysiol. 2024 Apr 17:e012666.
    PubMed        
    
    

    
    Circ Genom Precis Med

18. AMOR-SALAMANCA A, Santana Rodriguez A, Rasoul H, Rodriguez-Palomares JF, et al
    Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction.
    Circ Genom Precis Med. 2024;17:e004404.
    PubMed         Abstract available
    
    
19. ANTONOPOULOS AS, Xintarakou A, Protonotarios A, Lazaros G, et al
    Imagenetics for Precision Medicine in Dilated Cardiomyopathy.
    Circ Genom Precis Med. 2024;17:e004301.
    PubMed         Abstract available
    
    

    
    Circ Res

20. CRUZ FM, Macias A, Moreno-Manuel AI, Gutierrez LK, et al
    Extracellular Kir2.1(C122Y) Mutant Upsets Kir2.1-PIP(2) Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome.
    Circ Res. 2024;134:e52-e71.
    PubMed         Abstract available
    
    

    
    Circulation

21. MAYER M
    Letter by Mayer Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
    Circulation. 2024;149:e1109-e1110.
    PubMed        
    
    
22. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
    Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
    Circulation. 2024;149:e1111-e1112.
    PubMed        
    
    

    
    Clin Cardiol

23. ITO R, Kondo Y, Nakano M, Kajiyama T, et al
    Interaction of left ventricular size with the outcome of cardiac resynchronization therapy in Japanese patients.
    Clin Cardiol. 2024;47:e24267.
    PubMed         Abstract available
    
    

    
    Eur Heart J

24. 
    Correction to: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
    Eur Heart J. 2024 Apr 17:ehae227. doi: 10.1093.
    PubMed        
    
    
25. CHEN Q, van Rein N, van der Hulle T, Heemelaar JC, et al
    Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study.
    Eur Heart J. 2024 Apr 15:ehae222. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

26. KAMSANI SH, Middeldorp ME
    Adherence in a fortnight: is this a true reflection of a lifetime?
    Heart. 2024 Feb 8:heartjnl-2023-323800. doi: 10.1136/heartjnl-2023-323800.
    PubMed        
    
    

    
    J Am Coll Cardiol

27. NASER JA, Alexandrino FB, Harada T, Michelena HI, et al
    The Natural History of Atrial Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024 Mar 17:S0735-1097(24)00413.
    PubMed         Abstract available
    
    

    
    J Cardiol

28. OKISHIGE K, Tachibana S, Shigeta T, Yamauchi Y, et al
    Novel method to avoid serious injurious effects on the atrioventricular nodal (AVN) conduction during catheter ablation of the AVN slow pathway utilizing cryofreezing energy.
    J Cardiol. 2024;83:371-376.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Electrophysiol

29. KATAOKA N, Imamura T
    How to demonstrate clinical implication of early catheter ablation for atrial fibrillation.
    J Cardiovasc Electrophysiol. 2024 Apr 17. doi: 10.1111/jce.16279.
    PubMed        
    
    
30. MARK ESTES NA
    Concise guidelines on catheter ablation of atrial fibrillation from the European Cardiac Arrhythmias Society.
    J Cardiovasc Electrophysiol. 2024 Apr 18. doi: 10.1111/jce.16278.
    PubMed        
    
    

    
    J Interv Card Electrophysiol

31. TZEIS S, Gerstenfeld EP, Kalman J, Saad E, et al
    2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.
    J Interv Card Electrophysiol. 2024 Apr 13. doi: 10.1007/s10840-024-01771.
    PubMed         Abstract available
    
    
32. OKUMUS NK, Zeitler EP, Moustafa A, Iglesias M, et al
    Three-year incidence of pacemaker implantation in patients with atrial fibrillation and sinus node dysfunction receiving ablation versus antiarrhythmic drugs.
    J Interv Card Electrophysiol. 2024 Apr 18. doi: 10.1007/s10840-024-01790.
    PubMed         Abstract available
    
    
33. O'LEARY ET, Sneider D, Przybylski R, Dionne A, et al
    Comparative utility of omnipolar and bipolar electroanatomic mapping methods to detect and localize dual nodal substrate in patients with atrioventricular nodal reentrant tachycardia.
    J Interv Card Electrophysiol. 2024 Apr 18. doi: 10.1007/s10840-024-01800.
    PubMed         Abstract available
    
    
34. ACOSTA JCZ, Kowlgi GN
    Redefining cardiac care: the promising horizon of epicardial pulse field ablation for postoperative atrial fibrillation.
    J Interv Card Electrophysiol. 2024 Apr 20. doi: 10.1007/s10840-024-01806.
    PubMed        
    
    
35. WANG Y, Feng X, Zhong G, Yang C, et al
    A "two-step classification" machine learning method for non-invasive localization of premature ventricular contraction origins based on 12-lead ECG.
    J Interv Card Electrophysiol. 2024;67:457-470.
    PubMed         Abstract available
    
    
36. TAKAHASHI M, Kujiraoka H, Arai T, Kimura T, et al
    New-onset atrial high-rate episodes between his bundle pacing and conventional right ventricular septum pacing in patients with atrioventricular conduction disturbance.
    J Interv Card Electrophysiol. 2024;67:471-477.
    PubMed         Abstract available
    
    
37. KUEFFER T, Stefanova A, Madaffari A, Seiler J, et al
    Pulmonary vein isolation durability and lesion regression in patients with recurrent arrhythmia after pulsed-field ablation.
    J Interv Card Electrophysiol. 2024;67:503-511.
    PubMed         Abstract available
    
    
38. TAN MC, Ang QX, Yeo YH, Deshmukh A, et al
    Thirty-day readmission after catheter ablation for ventricular tachycardia: associated factors and outcomes.
    J Interv Card Electrophysiol. 2024;67:513-521.
    PubMed         Abstract available
    
    
39. BANSMANN PM, Mohsen Y, Horlitz M, Stockigt F, et al
    Optimizing fibrosis detection: a comparison of electroanatomical mapping and late enhancement gadolinium magnetic resonance imaging.
    J Interv Card Electrophysiol. 2024;67:571-577.
    PubMed         Abstract available
    
    
40. DARDEN D, Bilal Munir M, Zimmerman S, Eskander M, et al
    Frailty and associated outcomes in patients undergoing percutaneous left atrial appendage occlusion: findings from the NCDR LAAO registry.
    J Interv Card Electrophysiol. 2024;67:625-635.
    PubMed         Abstract available
    
    
41. VIPPARTHY S, Ravi V
    Does conduction system pacing result in a lower atrial arrhythmia burden compared to right ventricular pacing?
    J Interv Card Electrophysiol. 2024;67:437-438.
    PubMed        
    
    
42. LIUBA I, Santangeli P
    The quest for achieving durable mitral isthmus block: probing the heights of the left lateral ridge.
    J Interv Card Electrophysiol. 2024;67:443-445.
    PubMed        
    
    

    
    J Thromb Thrombolysis

43. MURAKAMI Y, Todo K, Uchida K, Yamagami H, et al
    One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke.
    J Thromb Thrombolysis. 2024;57:622-629.
    PubMed         Abstract available
    
    
44. MWITA JC, Francis JM, Pillay C, Ogah OS, et al
    Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa.
    J Thromb Thrombolysis. 2024;57:613-621.
    PubMed         Abstract available
    
    
45. AKHAN O, Boz M, Guzel T, Kis M, et al
    Discrimination of the acute pulmonary embolism subtypes based on the novel MAPH score.
    J Thromb Thrombolysis. 2024;57:683-690.
    PubMed         Abstract available
    
    

    
    N Engl J Med

46. LEE TC, Kaul S, Mandrola J
    Stroke Prevention in Subclinical Atrial Fibrillation.
    N Engl J Med. 2024;390:1441.
    PubMed        
    
    
47. ALLEN AL, Kibert J 2nd, Wall TS
    Stroke Prevention in Subclinical Atrial Fibrillation.
    N Engl J Med. 2024;390:1441-1442.
    PubMed        
    
    
48. HEALEY JS, Lopes RD
    Stroke Prevention in Subclinical Atrial Fibrillation. Reply.
    N Engl J Med. 2024;390:1442.
    PubMed        
    
    

    
    Pacing Clin Electrophysiol

49. HUANG JH, Lin YK, Hsieh MH, Chen SA, et al
    Ventricular response as a predictor of the termination of sustained paroxysmal atrial fibrillation.
    Pacing Clin Electrophysiol. 2024 Apr 17. doi: 10.1111/pace.14985.
    PubMed         Abstract available
    
    

    
    PLoS One

50. VON FALKENHAUSEN AS, Wischmann J, Keidel LM, Kellnar AM, et al
    Clinical practice of continuous rhythm monitoring after embolic stroke of undetermined source.
    PLoS One. 2024;19:e0302404.
    PubMed         Abstract available
    
    
51. HULSTAERT L, Boehme A, Hood K, Hayden J, et al
    Assessing ascertainment bias in atrial fibrillation across US minority groups.
    PLoS One. 2024;19:e0301991.
    PubMed         Abstract available
    
    
52. CHANG PC, Lee HL, Wo HT, Liu HT, et al
    Vericiguat suppresses ventricular tachyarrhythmias inducibility in a rabbit myocardial infarction model.
    PLoS One. 2024;19:e0301970.
    PubMed         Abstract available
    
    
53. OKENOV A, Nezlobinsky T, Zeppenfeld K, Vandersickel N, et al
    Computer based method for identification of fibrotic scars from electrograms and local activation times on the epi- and endocardial surfaces of the ventricles.
    PLoS One. 2024;19:e0300978.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

54. OKABE Y, Murakoshi N, Kurebayashi N, Inoue H, et al
    An inherited life-threatening arrhythmia model established by screening randomly mutagenized mice.
    Proc Natl Acad Sci U S A. 2024;121:e2218204121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.